相关实验视频

Updated: Jul 4, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

在癌症治疗中精确降解蛋白质的PROTAC-生物宏分子合物:一篇综述

Chao Wang¹, Yujing Zhang², Wanpeng Yu³

¹Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266071, Shandong, China.

International journal of biological macromolecules

|February 1, 2024

概括

针对蛋白质分解的嵌合体 (PROTAC) 技术显示了针对蛋白质降解的前景. PROTAC-生物大分子合物 (PBC) 提高了向性,降低了毒性,为更安全的癌症治疗铺平了道路.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

化向合体 (PROTAC) 技术为向蛋白质降解提供了一种新的方法,具有显著的治疗潜力.
临床应用的一个主要挑战,特别是在癌症治疗中,是对健康细胞的点毒性,非瘤毒性.
优化降解活动和细胞选择性至关重要,以尽量减少不良副作用.

研究的目的:

审查PROTAC生物大分子合物 (PBC) 的最新进展.
讨论与PBC相关的当前挑战.
概述目标蛋白质降解领域的未来研究机会.

主要方法:

关于PROTAC技术和生物宏分子合物的最新科学文献的综述.
分析将PROTAC与生物大分子 (如抗体和体) 结合在一起的策略.
综合有关PROTAC-生物巨分子合物 (PBC) 开发和应用的信息.

主要成果:

合PROTAC-抗体和合PROTAC-aptamer是一种创新的方法.
这些PROTAC-生物大分子合物 (PBCs) 显示出PROTACs的增强向性.
PBC显示了减少非目标副作用的潜力,改善了安全性.

结论:

强效的PROTACs和安全的生物大分子的组合是向蛋白质降解的先驱趋势.
为了克服PROTAC技术的毒性挑战,PROTAC-生物大分子合物 (PBC) 是一个有前途的策略.
对PBC的进一步研究为推进癌症治疗和其他疾病治疗提供了重大机会.

关键词:

生物巨分子分子癌症治疗治疗癌症治疗在PBCs中,PBCs是PBCs.这就是 PROTACs.

更多相关视频

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

The Proteasome Structure

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...